Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoma, Solid Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00002625
What this trial is testing

Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
Esophageal CancerLung CancerLymphoma
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439110
What this trial is testing

Testing Ado-Trastuzumab Emtansine as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol Q)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 38
Early research (Phase 1)Study completedNCT03707093
What this trial is testing

Study of CD137 Agonist ADG106 With Advanced or Metastatic Solid Tumors and/or Non-Hodgkin Lymphoma

Who this might be right for
Solid Tumors, Non-Hodgkin Lymphoma
Adagene Inc 49
Early research (Phase 1)Study completedNCT01121133
What this trial is testing

Assess the Effect of Rifampin on the Metabolism of Navitoclax

Who this might be right for
Lymphoma, Including Chronic Lymphocytic LeukemiaSolid Tumors
AbbVie 12
Early research (Phase 1)Study completedNCT01588548
What this trial is testing

Global Phase1 Study to Assess the Safety and Tolerability of AZD1208 in Advanced Solid Tumors and Malignant Lymphoma

Who this might be right for
Advanced Solid MalignanciesMalignant Lymphoma
AstraZeneca 43
Early research (Phase 1)Study completedNCT02635672
What this trial is testing

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Who this might be right for
Neoplasms
Vincerx Pharma, Inc. 110
Testing effectiveness (Phase 2)Active Not RecruitingNCT06400225
What this trial is testing

Testing BVD-523FB (Ulixertinib) as Potentially Targeted Treatment in Cancers With Genetic Changes (MATCH - Subprotocol Z1L)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more
National Cancer Institute (NCI) 35
Early research (Phase 1)Study completedNCT00004189
What this trial is testing

Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 40
Large-scale testing (Phase 3)Ended earlyNCT01132547
What this trial is testing

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Who this might be right for
Cancer
University of South Florida 22
Early research (Phase 1)Study completedNCT00364676
What this trial is testing

Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease

Who this might be right for
TumorsHodgkins DiseaseNon-Hodgkins Lymphoma
Spectrum Pharmaceuticals, Inc 67
Not applicableNot Yet RecruitingNCT07198958
What this trial is testing

Immune Adverse Events Registry in Onco-Hematologic Patients Treated With Immunotherapy

Who this might be right for
CancerCancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)Cancer (Solid Tumors)+1 more
IRCCS San Raffaele 500
Early research (Phase 1)Study completedNCT00688415
What this trial is testing

Safety and Pharmacologic Study of VTX-2337 in Patients With Advanced Cancer

Who this might be right for
Advanced Solid TumorsLymphoma
Celgene 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439344
What this trial is testing

Testing Binimetinib as a Potential Targeted Treatment in Cancers With NRAS Genetic Changes (MATCH-Subprotocol Z1A)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 53
Testing effectiveness (Phase 2)Looking for participantsNCT03297606
What this trial is testing

Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)

Who this might be right for
Lymphoma, Non-HodgkinMultiple MyelomaAdvanced Solid Tumors
Canadian Cancer Trials Group 720
Testing effectiveness (Phase 2)Active Not RecruitingNCT05490771
What this trial is testing

Testing Copanlisib as a Potential Targeted Treatment in Cancers With PIK3CA Mutations (MATCH-Subprotocol Z1F)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphatic System Neoplasm+3 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Looking for participantsNCT07285044
What this trial is testing

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

Who this might be right for
AmyloidosisBasal Cell CarcinomaBiliary Tract Carcinoma+26 more
Mayo Clinic 27
Large-scale testing (Phase 3)UnknownNCT01316744
What this trial is testing

Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain

Who this might be right for
Cancer
University of Glasgow 214
Early research (Phase 1)Study completedNCT01460134
What this trial is testing

CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

Who this might be right for
CD27 Expressing B-cell Malignancies for Example Hodgkin's LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+7 more
Celldex Therapeutics 90
Early research (Phase 1)Ended earlyNCT06870487
What this trial is testing

Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers

Who this might be right for
Peripheral T Cell LymphomaDiffuse Large B-cell LymphomaClassical Hodgkin Lymphoma+3 more
Pfizer 6
Early research (Phase 1)UnknownNCT04651348
What this trial is testing

A Clinical Study of MIL95 in Advanced Malignancies.

Who this might be right for
Advanced Malignancies
Beijing Mabworks Biotech Co., Ltd. 58
Next Page